The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series

作者：Thomas L. Schwartz, Maurizio Fava · 发表于：Psychopharmacology Bulletin · 年份：2025 · DOI：10.64719/pb.4223 · 被引用次数：31 · 研究领域：Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes、Mindfulness and Compassion Interventions、Treatment of Major Depression

Tiagabine is currently approved by the Food and Drug Administration for use in treating certain forms of epilepsy. Like other anticonvulsant agents, tiagabine has been explored for use as a mood stabilizer and in panic disorder. This article presents a case series of five patients who were prescribed tiagabine for treatment-resistant anxiety.